Total femur prosthesis in oncological and not oncological series. Survival and failures.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 31889744.
- Also identified by DOI 10.1016/j.jor.2019.11.009 and PMC identifier 6928329.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Total femur prosthesis (TFP) can be used in both oncological and prosthetic revision surgery. A retrospective analysis of 32 patients receiving a TFP at a single Center between 2002 and 2018 was performed. The average follow-up was 60 months. Revision implant free survival (RIFS) of the implants was 87% at 5 and 10 years and 72% at 15 years. Overall implant survival (OIS) of the prosthesis was 90% at 5, 10 and 15 years. Complications observed: two soft tissue failures, two infection failure and one tumor progression failure.
Anatomy
- femur